The Girl Scouts is being sued for allegedly selling cookies that contain "heavy metals." The organization pushes back against ...
As earnings season begins, filings to the SEC point to uncertainty from the current administration as potential trouble for ...
Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...
If confirmed by the US Senate, Dr. Oz could oversee health insurance programs covering approximately 150 million Americans.
Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...
BOSTON, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that the ...
U.S. Customs and Border Protection has launched a new mobile app to give undocumented migrants, whose parole has been revoked ...
The Senate health committee announced Thursday morning that it was canceling a planned hearing on Weldon’s nomination because ...
All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.
High-profile Republican priorities are advancing after the Iowa Legislature's first "funnel" deadline on Friday, while others ...
18d
Stocktwits on MSNHims & Hers Retail Traders Eye Robust Post-Earnings Rebound Following Stock’s Worst Drop On Semaglutide UpdateHims & Hers Health Inc. (HIMS) stock tumbled over 25% on Friday, extending losses in after-hours trading after the U.S. Food and Drug Administration (FDA) officially resolved the semaglutide shortage.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results